Filter
2068
Filtered Results: 2068
Text search:
People
who
inject
drugs
Featured
Recommendations
214
New Publications
480
Language
Document type
No document type
1228
Studies & Reports
323
Guidelines
291
Manuals
64
Strategic & Response Plan
53
Fact sheets
43
Training Material
37
Infographics
14
Situation Updates
11
Brochures
2
Resource Platforms
2
Countries / Regions
India
77
Global
66
Kenya
58
Nepal
46
South Africa
45
Western and Central Europe
43
Tanzania
42
Ukraine
34
Nigeria
31
Ethiopia
31
Sierra Leone
30
Myanmar / Burma
29
Latin America and the Carribbean
28
Asia
26
Uganda
25
Zambia
25
Malawi
24
Eastern Europe
23
Liberia
23
Bangladesh
22
Africa
20
Russia
19
Ghana
17
Philippines
17
South–East Asia Region
14
Namibia
14
Rwanda
13
Senegal
13
Cambodia
11
Indonesia
11
Tajikistan
10
Lesotho
10
Albania
10
Mozambique
10
Congo, Democratic Republic of
9
Botswana
8
Burkina Faso
7
Zimbabwe
7
Brazil
7
Georgia
7
Pakistan
7
North Macedonia
6
Cameroon
6
Armenia
6
Germany
6
West and Central Africa
6
Middle East and North Africa
6
East and Southern Africa
6
Moldova
6
Yemen
6
South Sudan
6
Colombia
5
Syria
5
Haiti
5
Eastern Europe and Central Asia
5
Guinea
4
Venezuela
4
Vietnam
4
Eswatini/ Swaziland
4
Serbia
3
China
3
Laos
3
Estonia
3
Afghanistan
3
Jordan
3
Argentina
3
Sudan
3
Mali
3
Thailand
2
Mexico
2
Turkey
2
Benin
2
Chile
2
Niger
2
Peru
2
Paraguay
2
North America
2
Uruguay
2
France
2
Spain
2
Southern Africa
2
Sri Lanka
2
Egypt
2
Romania
2
Honduras
2
Libya
2
Somalia
2
Madagascar
2
El Salvador
1
Gambia
1
Kazakhstan
1
Iran
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Burundi
1
Qatar
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
Western Pacific Region
1
Jamaica
1
Belgium
1
Mauritius
1
United Kingdom
1
Portugal
1
Belarus
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Palestine
1
Poland
1
Angola
1
Chad
1
Bhutan
1
Iraq
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
620
Clinical Guidelines
206
Public Health
85
Women & Child Health
53
Key Resources
44
Capacity Building
31
Pharmacy & Technologies
21
Annual Report MEDBOX
1
Toolboxes
HIV
545
TB
231
NTDs
136
COVID-19
113
Mental Health
83
AMR
72
Rapid Response
52
Ebola & Marburg
41
Pharmacy
32
Planetary Health
29
Refugee
28
Caregiver
24
Zika
18
NCDs
14
Health Financing Toolbox
13
Conflict
11
Global Health Education
11
Polio
10
Specific Hazards
7
Cholera
7
Natural Hazards
6
Malaria
5
Disability
3
The study collected data on the impact of HIV-related diseases on income, revenues, economic dependency, consumption, education, health, food security, stigma, discrimination, quality of life, and migration. The study also assessed people living with chronic diseases in order to compare the impact o...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
Policy brief.
Globally, one in five people with HIV are unaware of their status, despite considerable scale up of HIV testing, treatment and prevention services. Many of those unreached by HIV testing services (HTS) are from key populations, partners of people with HIV and, in Eastern and southern ...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
One key aim of tuberculosis (TB) prevention and care is to render them more people-centred, which means further boosting and improving ambulatory care models across the countries of Eastern Europe and central Asia. This note is intended to remind interested parties of the evidence that shows that am...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...
The publication conveys the quantitative surveillance results focusing on tobacco use and noncommunicable disease (NCD) related behaviours among youth (13–15 years) in Member States of the WHO South-East Asia Region, namely, the Global School-based Student Health Survey (GSHS) and the Global Youth...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
